Search
for
Sort by
Research 661–690 of 1000+
- In vivo skin leptin modulation after 14 MeV neutron irradiation: a molecular and FT-IR spectroscopic study
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Transdifferentiation of Human Hair Follicle Mesenchymal Stem Cells into Red Blood Cells by OCT4
- In Vitro Stability and Preclinical Safety Evaluation of High-Dose Intravitreal Topotecan in Rabbits: Impact of Dose and Concentration
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- Optimizing Scalp Cooling: (Ultra)Structural Follicular Characteristic and Restorative Advances
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Erythroderma, Alopecia, Anhidrosis, and Vitiligo as Complications of a Red Ink Tattoo—A Case Report
- Telitacicept for systemic lupus erythematosus with post‑surgical papillary thyroid carcinoma: A case report
- Hair restoration surgery: pre-surgical considerations and pitfalls
- Iron Deficiency in Menstruating Adult Women: Much More than Anemia
- Homozygous whole body <i>Cbs</i> knockout in adult mice features minimal pathology during ageing despite severe homocysteinemia
- A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants
- Comparative Evaluation of Buffy Coat–Derived and Apheresis Platelet-Rich Plasma in the Treatment of Androgenetic Alopecia: Laboratory and Clinical Insights
- Comparative Evaluation of Buffy Coat–Derived and Apheresis Platelet-Rich Plasma in the Treatment of Androgenetic Alopecia: Laboratory and Clinical Insights
- Insulin Resistance in an Underweight Woman with Polycystic Ovary Syndrome: A Case Study
- First National Chemotherapy Safety Standards Issued Jointly by ASCO & ONS
- The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Biologics in the management of childhood atopic dermatitis
- Challenges associated with the identification of germline variants on myeloid malignancy genomic profiling—a Singaporean experience
- Cold Atmospheric Plasma for Breast Cancer
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Congenital insensitivity to pain with anhidrosis and progressing acro-osteolysis: a case report with 7-year follow-up
- Skin manifestations associated with systemic diseases – Part I
- The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial